Eugeniusz J. Kucharz

Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial

Dinesh Khanna, Celia J. F. Lin, Daniel E. Furst et al. · The Lancet Respiratory Medicine · 2020 · 612 citations · Full text

Autoimmune Disease, Systemic Scleroderma, Immunology +3

Free radical activity and antioxidant defense mechanisms in patients with hyperthyroidism due to Graves’ disease during therapy

Katarzyna Komosińska‐Vassev, Krystyna Olczyk, Eugeniusz J. Kucharz et al. · Clinica Chimica Acta · 2000 · 139 citations

Oxysterol, Medicine, Physiology +8

Infliximab Treatment Increases Left Ventricular Ejection Fraction in Patients with Rheumatoid Arthritis: Assessment of Heart Function by Echocardiography, Endothelin 1, Interleukin 6, and NT-pro Brain Natriuretic Peptide

Przemysław Kotyla, Aleksander Owczarek, Jarosław Rakoczy et al. · The Journal of Rheumatology · 2012 · 58 citations · Full text

Is there a role for TNFα antagonists in the treatment of SSc? EUSTAR expert consensus development using the Delphi technique.

Joerg H W Distler, Suzana Jordan, Juan José Alegre Sancho et al. · PubMed · 2011 · 49 citations

Impaired T-cell activation in patients with systemic lupus erythematosus

Stanisław Sierakowski, Eugeniusz J. Kucharz, Robert W. Lightfoot et al. · Journal of Clinical Immunology · 1989 · 42 citations

Autoimmune Disease, Systemic Lupus Erythematosus Treatment, Lupus +7